Charles River Labs (CRL) PT Raised to $128 at Barclays
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $181.56 -1.86%
Rating Summary:
22 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
22 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Barclays analyst Jack Meehan raised the price target on Charles River Labs (NYSE: CRL) to $128.00 (from $120.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Charles River Labs (CRL) to Overweight, 'strong uptick in biopharma funding beginning to transition into RFPs and bookings'
- Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold
- Robinhood Markets (HOOD) PT Raised to $130 at Cantor Fitzgerald
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
